Petrus Trust Company, Lta Bristol Myers Squibb CO Transaction History

Petrus Trust Company, Lta

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $250,011 - $298,332	5,157 New	5,157 $264,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $282,069 - $334,009	4,119 New	4,119 $296,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $334,283 - $436,042	-6,793 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $51,965 - $61,612	-1,215 Reduced 15.17%	6,793 $344,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $110,256 - $121,919	-2,471 Reduced 23.58%	8,008 $363,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $472,812 - $563,770	10,479 New	10,479 $500,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.